✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
No serious adverse reactions attributable to the vaccine, were observed.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults.
📊
Key Findings & Data:Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule.
💡
Conclusion & Impact:No serious adverse reactions attributable to the vaccine, were observed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatitis B · prevention and control
Abstract
We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults. Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule. One month after the third dose, seroconversion rate was 100% and all subjects had antibodies to hepatitis B surface antigen tilers in excess of 10IU / L. No serious adverse reactions attributable to the vaccine, were observed.
🔖
Cite This Article
Pamukçu, M., Mutlu, G., Yakupoğlu, G., Süleymanlar, G., Yeğin, 0. (1991). Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal, Volume: 4 Issue: 1. https://ajindex.com/articles/1287705